Literature DB >> 16308469

The role of macrophages in tumor development.

Gerben J van der Bij1, Steven J Oosterling, Sybren Meijer, Robert H J Beelen, Marjolein van Egmond.   

Abstract

Macrophages constitute a large proportion of the immune cell infiltrate, which is present in many tumors. Activation state of macrophages is greatly influenced by their environment, leading to different macrophage subsets with diverse functions. Although previously regarded as potent immune cells that are capable of destroying tumor cells, recent literature focuses on the ability of macrophages to promote tumor development due to secretion of mediators, like growth and angiogenic factors. It is now becoming increasingly clear that a complicated synergistic relationship exists between macrophages and malignant cells whereby tumor cells can affect macrophage phenotype, and vice versa. As such, macrophages and their contribution in cancer development are currently subject of debate.

Entities:  

Mesh:

Year:  2005        PMID: 16308469      PMCID: PMC4617500          DOI: 10.1155/2005/719412

Source DB:  PubMed          Journal:  Cell Oncol        ISSN: 1570-5870            Impact factor:   6.730


  13 in total

1.  Effect of beta blocker combined with COX-2 inhibitor on colonic anastomosis in rats.

Authors:  Barak Benjamin; Ofir Hazut; Lee Shaashua; Marganit Benish; Niv Zmora; Iris Barshack; Aviad Hoffman; Shamgar Ben-Eliyahu; Oded Zmora
Journal:  Int J Colorectal Dis       Date:  2010-06-16       Impact factor: 2.571

Review 2.  Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages.

Authors:  Robert D Stout; Stephanie K Watkins; Jill Suttles
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

3.  Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression.

Authors:  Stephanie K Watkins; Bing Li; Katharine S Richardson; Kimberly Head; Nejat K Egilmez; Qun Zeng; Jill Suttles; Robert D Stout
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

4.  Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.

Authors:  Manuela Banciu; Josbert M Metselaar; Raymond M Schiffelers; Gert Storm
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

5.  Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform.

Authors:  David P Cormode; Torjus Skajaa; Matti M van Schooneveld; Rolf Koole; Peter Jarzyna; Mark E Lobatto; Claudia Calcagno; Alessandra Barazza; Ronald E Gordon; Pat Zanzonico; Edward A Fisher; Zahi A Fayad; Willem J M Mulder
Journal:  Nano Lett       Date:  2008-10-22       Impact factor: 11.189

6.  Carcinoma origin dictates differential skewing of monocyte function.

Authors:  Marijn Bögels; Rens Braster; Philip G Nijland; Nuray Gül; Wendy van de Luijtgaarden; Remond J A Fijneman; Gerrit A Meijer; Connie R Jimenez; Robert H J Beelen; Marjolein van Egmond
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

Review 7.  Immune suppression in head and neck cancers: a review.

Authors:  Anaëlle Duray; Stéphanie Demoulin; Pascale Hubert; Philippe Delvenne; Sven Saussez
Journal:  Clin Dev Immunol       Date:  2011-03-10

8.  Bioincompatible impact of different peritoneal dialysis fluid components and therapeutic interventions as tested in a rat peritoneal dialysis model.

Authors:  Andrea W D Stavenuiter; Karima Farhat; Margot N Schilte; Piet M Ter Wee; Robert H J Beelen
Journal:  Int J Nephrol       Date:  2011-08-02

Review 9.  Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression.

Authors:  Ki-Jong Rhee; Jong In Lee; Young Woo Eom
Journal:  Int J Mol Sci       Date:  2015-12-16       Impact factor: 5.923

10.  Strategies to increase drug penetration in solid tumors.

Authors:  Il-Kyu Choi; Robert Strauss; Maximilian Richter; Chae-Ok Yun; André Lieber
Journal:  Front Oncol       Date:  2013-07-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.